SLMENA joins Qatar Health Congress
SLMENA Featured in MASLD–MASH Scientific Session at Qatar Health Congress 2026 The Steatotic Liver Disease Foundation – Middle East & North Africa […]
Read more
New Bilateral Endorsement
We are proud to announce a new partnership between the Steatotic Liver Disease Study Foundation in Middle East and North Africa (SLMENA) […]
Read moreMultidisciplinary Team Management of Hepatocellular Carcinoma in the MENA Region: Current Practices, Challenges, and Gaps
Authors El-Kassas M, Khalifa R , AlNaamani KM, Shousha H, Yilmaz Y , Sanai FM, Almattooq M , Labidi A, Akroush MWI, Debzi N, Abdelmalek MO, Abdeen NS, Tumi A, Elbadry M, El Fouly A, Marwan E, Al Suwaidi J, Elzouki AN , Alswat KA […]
Read moreLubiprostone Reduces Fat Content on MRI-PDFF in Patients With MASLD: A 48-Week Randomised Controlled Trial
Mohamed El-Kassas, Hala Mostafa, Wessam Abdellatif, Sohier Shoman, Gamal Esmat, Mayur Brahmania, Hongqun Liu, Samuel S. Lee First published: 02 January 2025 https://doi.org/10.1111/apt.18478 Citations: 4 Handling Editor: Rohit Loomba Funding: The authors […]
Read moreSteatotic liver disease as a new nomenclature for NAFLD from the perspectives of the MENA region: One size fits all this time
Mohamed El-Kassas1 m_elkassas@hq.helwan.edu.eg ∙ Khalid Alswat2 on behalf of the Steatotic Liver Disease Study Foundation in Middle East and North Africa (SLMENA) Full Article Here: https://www.journal-of-hepatology.eu/article/S0168-8278(23)05065-1/fulltext
Read moreShedding lights on diagnostic challenges in Wilson’s disease: The positive impact of introducing steatotic liver disease new nomenclature umbrella
Marwa Khalaf Hassan, Khalid Alswat, Mohamed El-Kassas First published: 12 February 2024 https://doi.org/10.1111/liv.15868 Full Article Here: https://onlinelibrary.wiley.com/doi/10.1111/liv.15868
Read moreEnhancing the Understanding of Liver Fibrosis in Type 2 Diabetes: Methodological Considerations and Future Directions
Mohamed El-Kassas m_elkassas@hq.helwan.edu.eg ∙ Khalid M. AlNaamani ∙ Yusuf Yilmaz ∙ Khalid A. AlswatAffiliations & NotesArticle Info Publication History: Received March 15, 2025; Accepted March 18, 2025; Published online March 25, 2025 DOI: 10.1016/j.jceh.2025.102553 External LinkAlso available […]
Read moreLetter: Addressing the Growing Disparities in Alcohol-Associated Liver Disease—A Call for Equitable Healthcare Strategies
Mohamed El-Kassas, Abdel-Naser Elzouki, Khalid M. AlNaamani First published: 22 April 2025 https://doi.org/10.1111/apt.70101 Citations: 1 Handling Editor: Rohit Loomba Funding: The authors received no specific funding for […]
Read moreRevisiting MASLD Nomenclature: Insights from the MENA Region and Its Clinical Relevance
Khalid Alswat kalswat@ksu.edu.sa ∙ Faisal Sanai ∙ Waleed K. Al-Hamoudi ∙ Mohamed El-Kassas Publication History: Received March 15, 2025; Accepted April 11, 2025; Published online April 17, 2025 DOI: 10.1016/j.jceh.2025.102581 External LinkAlso available on ScienceDirect External Link Copyright: © […]
Read moreLetter: Lubiprostone Treatment for MASLD—Gender Imbalance and Blinding Considerations. Authors’ Reply
Mohamed El-Kassas, Hala Mostafa, Hongqun Liu, Samuel S. Lee First published: 03 April 2025 https://doi.org/10.1111/apt.70132 Handling Editor: Rohit Loomba Funding: The authors received no specific funding for […]
Read more